DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Cassidy J, Douillard JY, Twelves C, McKendrick JJ, Scheithauer W, Bustová I. et al.
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes’ C colon cancer: The X-ACT trial.
Br J Cancer 2006;
94: 1122-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.